Partner Sites
  • Executive War College
  • The Dark Report
  • Dark Daily
  • G2 Intelligence
Today's Clinical Lab Logo
  • Trends
  • Events
    • Digital Forums
    • Webinars
  • Resources
    • Ebooks
    • Infographics
    • White Papers
    • Magazine

LoginSubscribe Today

  • Business & Policy
    • Advocacy & Professional Affairs
    • FDA, CMS & Regulatory Frameworks
    • IVD Market
    • M&A, Consolidation & Competitive Landscape
    • Market Trends & Business Intelligence
    • Payer Policy
    • Public Health & Population Testing Strategy

  • Lab Operations
    • Budgeting, Cost Control & Purchasing Strategy
    • Procurement & Vendor Alignment
    • Remote/Hub-and-Spoke Testing Networks
    • Revenue Cycle Management
    • Sustainability & Resource Efficiency
    • Workflow Optimization & Lean Lab Design
    • Workforce, Staffing & Training

  • Compliance
    • Biosafety, Biosecurity & Risk Management
    • CLIA, Regulatory, & Accreditation
    • Data Integrity & Traceability
    • Proficiency Testing & External QC
    • Quality Control & Quality Assurance
    • Validation, Verification & Method Comparison

  • Emerging Tech
    • Cell & Gene Therapy Diagnostic Interfaces
    • Digital Pathology, AI & Computational Diagnostics
    • Genomics, Proteomics, & Metabolomics
    • Liquid Biopsy & Early Detection
    • Precision Medicine & Companion Diagnostics

  • Tools & Techniques
    • Analyzers, Automation, & Diagnostic Platforms
    • Consumables & Lab Supplies
    • LIMS, Data Systems & Digital Workflows
    • Liquid Handling & Laboratory Robotics
    • Microscopy & Digital Pathology Imaging
    • PCR & qPCR Systems
    • Sample Prep & Processing Systems
    • Sequencing & Multiomics Platforms

  • Diagnostics & Testing
    • Clinical Chemistry
    • Hematology, Hemostasis, & Urinalysis
    • Microbiology & Infectious Disease
    • Molecular Diagnostics
    • Pathology & Histology
    • Point-of-Care Testing
    • Specimen Collection, Transport, & Pre-Analytical Processes
    • Toxicology & Pharmacology

Today's Clinical Lab LogoToday's Clinical Lab Logo
SubscribeSubscribe Today
  • Home/
  • Trends/
  • Neuroscience Testing and Research
7-Part Series

Neuroscience Testing and Research

Exploring genetics, biomarkers, and research on neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, focusing on early testing and detection, and therapeutic advances.
Read Series
Exploring genetics, biomarkers, and neuroscience research in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, focusing on mechanisms, early detection, and therapeutic advances.
Published

Articles in this Series

The FNIH Biomarkers Consortium has been asking "what’s next" in the Alzheimer’s space for over 20 years.
|4 min read

Counting Down to Alzheimer’s Disease

byZahraa Chorghay, PhD
The consortium includes data from more than 35,000 biofluid samples, leading to approximately 250 million unique protein measurements.
|5 min read

Global Neurodegeneration Proteomics Atlas Reveals Key Disease Signatures

byZahraa Chorghay, PhD
Addressing the complex biology of progression is a major challenge in managing MS patients.
|3 min read

Capturing the Elusive: Why Multi-Protein Biomarkers Tests Are the Future of Measuring MS Progression

byFerhan Qureshi
A critical challenge in treating, researching, and living with multiple sclerosis is that MRI and neurological exams identify disease changes only after they have occurred.
|3 min read

The Future of Biomarkers in Multiple Sclerosis Care

byStephanie Buxhoeveden, PhD, MSN, FNP-BC, MSCN
Photo of a shape in the form of the human brain sculped from aluminum foil on a white background.
Updated |3 min read

New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments

byRuss Lebovitz, MD, PhD
Tubes of blood and urine of a patient with a test report for analysis in the background.
|4 min read

Discovering Novel Biomarkers for Rare Neurological Diseases

byJordan Willis, BSc
Woman with MS in wheelchair carries an umbrella for the sun and looks hopeful for a cure for MS.
|3 min read

Multiple Sclerosis as a Case of Mistaken Identity

byZahraa Chorghay, PhD
Read Series
Today's Clinical Lab Logo

Get to Know Us

  • Topics

    • Emerging Diagnostic Modalities & Innovation
    • Industry, Policy & Workforce
    • Instruments, Equipment & Technology
    • Lab Operations & Management
    • Laboratory Science & Testing
    • Quality, Standards & Compliance
  • Trends

    • All Trends
    • Clinical Informatics
    • Combating Antimicrobial Resistance
    • Digital Pathology
    • Genetic Testing
    • Laboratory Developed Tests
  • About

    • About Us
    • Meet the Team
    • Contact Us
    • Privacy Policy
    • Cookie Policy
  • Resources

    • eBooks
    • Infographics
    • Magazine
    • White Papers
  • Events

    • All Events
    • Webinars
    • Digital Forums
  • Editorial & Advertising

    • Editorial Standards & Policies
    • Contributor Guidelines
    • Advertise

Catch up on all the latest in

Clinical Lab Management
Today's Clinical Lab homepage displayed on laptop, tablet, and phoneSubscribe for Free
Partner Sites
  • Executive War College
  • The Dark Report
  • Dark Daily
  • G2 Intelligence
  • Executive War College Logo
  • The Dark Report Logo
  • Dark Daily Logo
  • G2 Logo

Part of the LabX Media Group:LabX Media Group|Privacy|Cookie Policy

© 2026 Today's Clinical Lab. All rights reserved.

This site is protected by reCAPTCHA and the GooglePrivacy PolicyandTerms of Serviceapply.

Test Follow